Julio del Rio-Garma

CURRENT RESEARCH LINES DIAGNOSIS: -Comparison of the FRETS and ELISA methods against determination of ADAMTS13 by chemiluminescence (in progress) -Phenotypic and genotypic characterization of congenital PTTs in Spain (In progress) CLINIC: -Mortality analysis in the REPTT years 2004-2018 (ongoing) -Validation of the international ADAMTS13 severe deficit prediction scores in the REPTT patient series (about to begin). TREATMENT: -Analysis of the safety and efficacy of Caplacizumab used as a foreign medicine (compassionate use) in PTTa in the first line or refractory PTTa